EL
33
-3
NEM
57
2
MHK
43
-2
HPE
50
-16
NTRS
64
-5
FFIV
67
-2
MTCH
46
-2
PFE
45
16
FOX
51
-2
GWW
60
-2
FRT
51
-2
GM
69
-3
EXPE
61
2
CCI
30
2
NEE
49
2
CTSH
52
-2
MSFT
65
-3
GT
42
-3
KMI
61
4
WEC
65
2
EL
33
-3
NEM
57
2
MHK
43
-2
HPE
50
-16
NTRS
64
-5
FFIV
67
-2
MTCH
46
-2
PFE
45
16
FOX
51
-2
GWW
60
-2
FRT
51
-2
GM
69
-3
EXPE
61
2
CCI
30
2
NEE
49
2
CTSH
52
-2
MSFT
65
-3
GT
42
-3
KMI
61
4
WEC
65
2
Financhill
Back

Avidity Biosciences Stock Predictions

Could BOXABL Be the Tesla of Housing?

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Sell
50

RNA
Avidity Biosciences

Last Price:
$30.39
Seasonality Move:
21.18%

7 Day Trial

ALL ACCESS PASS

$ 7

This $60K Foldable Home Is Shaking Up Real Estate

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.

Avidity Biosciences Stock Forecast

  • Over the next 52 weeks, Avidity Biosciences has on average historically risen by 29.3% based on the past 4 years of stock performance.
  • Avidity Biosciences has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Avidity Biosciences Stock Undervalued?
    The current Avidity Biosciences [RNA] share price is $30.58. The Score for RNA is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Avidity Biosciences Stock Go Up Next Year?

  • Over the next 52 weeks, Avidity Biosciences has on average historically risen by 29.3% based on the past 4 years of stock performance.

Avidity Biosciences Stock Rating

Sell
50
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences overpriced?

  • Avidity Biosciences has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Avidity Biosciences Stock Price History

Is RNA stock going to rise?

  • The current trend is moderately bullish and RNA is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
aviditybiosciences.com

52-Week Data

52-Week High:
56.00
52-Week Low:
21.51

Prediction Charts

Market Cap:
3.7B
Price in USD:
30.58
Volume:
455.2K
Beta:
1.01

Technical Analysis

SMA50:
29.49
SMA100:
30.22
SMA200:
36.50
52-Wk Change:
11.32%

Stock Predictions

  • Is Avidity Biosciences stock public?
    Yes, Avidity Biosciences is a publicly traded company.
  • What is the Avidity Biosciences stock quote today?
    The Avidity Biosciences stock price is 30.58 USD today.
  • How to buy Avidity Biosciences stock online?
    You can buy Avidity Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-6 31.85 26.26 32.03 25.71
May-7 27.11 26.17 27.41 25.58
May-8 26.18 28.69 29.85 25.67
May-9 29.00 27.87 30.25 27.80
May-12 28.48 29.33 31.20 28.48
May-13 29.72 29.88 29.98 28.18
May-14 30.19 28.40 30.84 27.71
May-15 28.35 28.97 29.09 27.65
May-16 29.00 30.35 30.45 28.78
May-19 29.80 30.22 31.18 29.21
May-20 30.18 31.64 31.71 29.60
May-21 31.14 30.62 31.77 30.00
May-22 30.14 30.81 31.00 29.44
May-23 29.96 30.58 30.77 29.86

Avidity Biosciences Earnings

Avidity Biosciences Earnings Report: Per Share Avidity Biosciences Earnings Q1 Q2 Q3 and Q4 last year and next year.

Avidity Biosciences Forecast Revenue Growth

Avidity Biosciences Stock Analysis: Historical quarterly revenues per share for Avidity Biosciences and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.13 per share, a decrease this year of $1.11 per share, and a decrease next year of $0.47 per share.

* Avidity Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.